First Personal Financial Services’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
– Sell
-1
Closed – – 395
2022
Q3
$0 Hold
1
– – ﹤0.01% 427
2022
Q2
$0 Hold
1
– – ﹤0.01% 327
2022
Q1
$0 Hold
1
– – ﹤0.01% 332
2021
Q4
$0 Buy
+1
New +$118 ﹤0.01% 341
2021
Q1
– Sell
-104
Closed -$10K – 304
2020
Q4
$10K Buy
+104
New +$11K ﹤0.01% 275
2019
Q3
– Sell
-583
Closed -$48K – 554
2019
Q2
$48K Sell
583
-43
-7% -$3.37K 0.01% 285
2019
Q1
$51K Hold
626
– – 0.02% 267
2018
Q4
$48K Buy
626
+16
+3% +$1.25K 0.02% 259
2018
Q3
$48K Buy
610
+104
+21% +$7.87K 0.02% 292
2018
Q2
$35K Sell
506
-1,283
-72% -$92.3K 0.01% 325
2018
Q1
$126K Sell
1,789
-263
-13% -$18.2K 0.03% 262
2017
Q4
$142K Buy
2,052
+350
+21% +$23.6K 0.03% 291
2017
Q3
$115K Hold
1,702
– – 0.02% 294
2017
Q2
$116K Hold
1,702
– – 0.03% 289
2017
Q1
$106K Hold
1,702
– – 0.03% 279
2016
Q4
$93K Buy
+1,702
New +$96.6K 0.02% 291
2016
Q2
– Sell
-58
Closed -$3K – 810
2016
Q1
$3K Buy
+58
New +$3.48K ﹤0.01% 297
2015
Q4
– Sell
-9
Closed -$1K – 402
2015
Q3
$1K Sell
9
-8
-47% -$526 ﹤0.01% 425
2015
Q2
$2K Hold
17
– – ﹤0.01% 383
2015
Q1
$2K Hold
17
– – ﹤0.01% 419
2014
Q4
$1K Buy
+17
New +$1.22K ﹤0.01% 399

Other funds holding AZN

First Personal Financial Services's AZN Position: Q4 2022 in Review

First Personal Financial Services sold out of AstraZeneca (AZN) in Q4 2022, closing a stake of 1 share.

First Personal Financial Services first reported a position in AZN in Q4 2014 and held it in 21 quarters. The position peaked at $142K in Q4 2017. 1,061 funds tracked by Wall St. Rank hold AZN as of Q4 2022.

  • First Personal Financial Services reported no remaining AstraZeneca position as of Q4 2022 after selling out during the quarter.
  • First Personal Financial Services sold 1 AstraZeneca share in Q4 2022.
  • First Personal Financial Services first reported a position in AstraZeneca in Q4 2014 and held it in 21 quarters.
  • First Personal Financial Services's AstraZeneca position peaked at $142K in Q4 2017.
  • 1,061 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2022.

Based on First Personal Financial Services's 13F filing for Q4 2022, filed 27 Jan 2023.